These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22036303)

  • 1. Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids.
    Daniulaityte R; Falck R; Carlson RG
    Drug Alcohol Depend; 2012 May; 122(3):201-7. PubMed ID: 22036303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Everything is not right anymore": Buprenorphine experiences in an era of illicit fentanyl.
    Silverstein SM; Daniulaityte R; Martins SS; Miller SC; Carlson RG
    Int J Drug Policy; 2019 Dec; 74():76-83. PubMed ID: 31563098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users.
    Bazazi AR; Yokell M; Fu JJ; Rich JD; Zaller ND
    J Addict Med; 2011 Sep; 5(3):175-80. PubMed ID: 21844833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent class analysis of non-opioid dependent illegal pharmaceutical opioid users in Ohio.
    Carlson RG; Nahhas RW; Daniulaityte R; Martins SS; Li L; Falck R
    Drug Alcohol Depend; 2014 Jan; 134():259-266. PubMed ID: 24210772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Illicit use of pharmaceutical opioids among young polydrug users in Ohio.
    Daniulaityte R; Falck RS; Wang J; Carlson RG
    Addict Behav; 2009 Aug; 34(8):649-53. PubMed ID: 19398164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study.
    Dreifuss JA; Griffin ML; Frost K; Fitzmaurice GM; Potter JS; Fiellin DA; Selzer J; Hatch-Maillette M; Sonne SC; Weiss RD
    Drug Alcohol Depend; 2013 Jul; 131(1-2):112-8. PubMed ID: 23333292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of non-prescribed buprenorphine and other opioid use among individuals with opioid use disorder: A latent class analysis.
    Daniulaityte R; Nahhas RW; Silverstein S; Martins S; Zaragoza A; Moeller A; Carlson RG
    Drug Alcohol Depend; 2019 Nov; 204():107574. PubMed ID: 31568934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "I'm not afraid of those ones just 'cause they've been prescribed": perceptions of risk among illicit users of pharmaceutical opioids.
    Daniulaityte R; Falck R; Carlson RG
    Int J Drug Policy; 2012 Sep; 23(5):374-84. PubMed ID: 22417823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Illicit use of opioid substitution drugs: prevalence, user characteristics, and the association with non-fatal overdoses.
    Bretteville-Jensen AL; Lillehagen M; Gjersing L; Andreas JB
    Drug Alcohol Depend; 2015 Feb; 147():89-96. PubMed ID: 25543167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Illicit use of methadone and buprenorphine among adolescents and young adults in Sweden.
    Richert T; Johnson B
    Harm Reduct J; 2013 Oct; 10():27. PubMed ID: 24139199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-medical use of pharmaceutical opioids with and without other illicit substances in Australia: Prevalence and correlates.
    Chan GCK; Leung J; Hall W
    Drug Alcohol Rev; 2019 Feb; 38(2):151-158. PubMed ID: 30652366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Motivations for Using Buprenorphine Products Differ From Using Opioid Analgesics: Evidence from an Observational Study of Internet Discussions Among Recreational Users.
    Butler SF; Oyedele NK; Dailey Govoni T; Green JL
    JMIR Public Health Surveill; 2020 Mar; 6(1):e16038. PubMed ID: 32209533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High enhancer, downer, withdrawal helper: Multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City.
    Mateu-Gelabert P; Jessell L; Goodbody E; Kim D; Gile K; Teubl J; Syckes C; Ruggles K; Lazar J; Friedman S; Guarino H
    Int J Drug Policy; 2017 Aug; 46():17-27. PubMed ID: 28577506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes and beliefs about Vermont's 2021 buprenorphine decriminalization law among residents who use illicit opioids.
    Feder KA; Harris SJ; Byrne L; Miller SM; Sodder S; Berman V; Livingston A; Edwards J; Hartman S; Sugarman OK; Shah H; Xu J; Raikes J; Gattine S; Saloner B
    Drug Alcohol Depend; 2023 Sep; 250():110879. PubMed ID: 37473698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence.
    Nielsen S; Lintzeris N; Murnion B; Degenhardt L; Bruno R; Haber P; Johnson J; Hardy M; Ling S; Saddler C; Dunlop A; Demirkol A; Silsbury C; Phung N; Houseman J; Larance B
    Drug Alcohol Rev; 2018 Nov; 37(7):887-896. PubMed ID: 30280448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sources of pharmaceutical opioids for non-medical use among young adults.
    Daniulaityte R; Falck R; Carlson RG
    J Psychoactive Drugs; 2014; 46(3):198-207. PubMed ID: 25052878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: A natural history study.
    Carlson RG; Nahhas RW; Martins SS; Daniulaityte R
    Drug Alcohol Depend; 2016 Mar; 160():127-34. PubMed ID: 26785634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid users' willingness to receive prolonged-release buprenorphine depot injections for opioid use disorder.
    Tompkins CNE; Neale J; Strang J
    J Subst Abuse Treat; 2019 Sep; 104():64-71. PubMed ID: 31370986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous misuse of buprenorphine: characteristics and extent among patients undergoing drug maintenance therapy.
    Moratti E; Kashanpour H; Lombardelli T; Maisto M
    Clin Drug Investig; 2010; 30 Suppl 1():3-11. PubMed ID: 20450240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Sub is a weird drug:" A web-based study of lay attitudes about use of buprenorphine to self-treat opioid withdrawal symptoms.
    Daniulaityte R; Carlson R; Brigham G; Cameron D; Sheth A
    Am J Addict; 2015 Aug; 24(5):403-9. PubMed ID: 26009867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.